BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22396112)

  • 1. Resistance of enterobacteria to carbapenem antibiotics is a global crisis.
    Tanne JH
    BMJ; 2012 Mar; 344():e1646. PubMed ID: 22396112
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishing surveillance for carbapenem-resistant Enterobacteriaceae in Minnesota, 2012.
    Shaw KM; Harper JE; Vagnone PS; Lynfield R
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):451-3. PubMed ID: 24602959
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors.
    Dirajlal-Fargo S; DeBiasi R; Campos J; Song X
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):447-9. PubMed ID: 24602957
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
    Temkin E; Adler A; Lerner A; Carmeli Y
    Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Enterobacteriaceae: a potential threat.
    Schwaber MJ; Carmeli Y
    JAMA; 2008 Dec; 300(24):2911-3. PubMed ID: 19109119
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
    Gupta N; Limbago BM; Patel JB; Kallen AJ
    Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Enterobacteriaceae: a growing threat.
    Nursing; 2013 Jul; 43(7):65. PubMed ID: 23778218
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
    Palmore TN; Henderson DK
    Ann Intern Med; 2014 Apr; 160(8):567-9. PubMed ID: 24733200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carbapenem resistance in enterobacteria].
    Hrabák J; Chudácková E
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):125-36. PubMed ID: 19069025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.
    Moran Gilad J; Carmeli Y; Schwartz D; Navon-Venezia S
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):565-7. PubMed ID: 21767716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
    Patel N; Harrington S; Dihmess A; Woo B; Masoud R; Martis P; Fiorenza M; Graffunder E; Evans A; McNutt LA; Lodise TP
    J Antimicrob Chemother; 2011 Jul; 66(7):1600-8. PubMed ID: 21508008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae.
    Drekonja DM; Beekmann SE; Elliott S; Mukundan D; Polenakovik H; Rosenthal ME; Tamma PD; Polgreen PM; Weissman SJ
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):437-9. PubMed ID: 24602953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
    Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
    J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).
    Basu S; Singh AK; Nair GB
    Natl Med J India; 2010; 23(5):261-2. PubMed ID: 21250578
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.
    Endimiani A; Paterson DL
    Semin Respir Crit Care Med; 2007 Dec; 28(6):646-55. PubMed ID: 18095228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new medical challenge: why NDM-1? Why Indian?
    Walsh TR; Toleman MA
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):137-41. PubMed ID: 21342058
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostics for superbugs.
    Raich TJ; Powell S
    MLO Med Lab Obs; 2013 Dec; 45(12):44, 46. PubMed ID: 24409596
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot testing of an out-of-country medical care questionnaire with screening and cost analysis of preemptive isolation for carbapenem-resistant Enterobacteriaceae in a large Canadian health region.
    Rajapakse N; Vayalumkal J; Lam-Li D; Pearce C; Rees G; Kamhuka L; Peirano G; Pidhorney C; Ledgerwood D; Alfieri N; Hope K; Gregson D; Pitout J; Louie T; Conly J
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):450-1. PubMed ID: 24602958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.